Thomas Leo Keller

Thomas Keller practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Thomas Keller's NPI, 1356761944, was assigned on April 22, 2014. Thomas Keller graduated from Georgetown University School of Medicine in 2014. Thomas Keller holds Washington license MD60754145.

Thomas Keller's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Thomas Keller's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Thomas Keller is also affiliated with Harborview Medical Center. The medical group on file is UW Physicians. Dmand AI also links Thomas Keller to 2 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thomas Keller practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Thomas Keller's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Thomas Keller is licensed in Washington.

CMS data shows 411 Medicare services from Thomas Keller across 7 procedure codes in 2024, for 143 Medicare patients. Medicare paid $37,573 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Thomas Keller in 2024. The largest group is 65 to 74, with 87 patients. 72% of them have high blood pressure, and 66% have chronic kidney disease. 19% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Thomas Keller's median patient age at 63, with 39% women.

In 2024, Thomas Keller wrote 813 Medicare Part D claims for 74 patients. 93% of them were for generic drugs. CMS names the drug for 677 of them, across 23 drugs with 11 or more claims each, at $235,534 in total drug cost. In 2023, CMS named 527 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Thomas Keller for performance year 2024, reported through an alternative payment model (APM). Thomas Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Thomas Keller as offering telehealth.

Thomas Keller graduated from Georgetown University School of Medicine in 2014.